An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer
Clinical trial NCT07300215 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07300215
- Sponsor
- The First Affiliated Hospital of Bengbu Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-20
- Primary completion
- 2027-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.